More
    Guided Solutions - Connecting Talent With Innovation/div>

    Clinical Trials

    Wandercraft launches clinical trial of Personal Exoskeleton technology

    Wandercraft kicked off a landmark clinical trial for its Personal Exoskeleton technology. The device aims to offer upright motion and walking independence for individuals...

    Newronika wins FDA IDE clearance for Adaptive DBS System clinical trial

    Newronika, the developer of groundbreaking adaptive deep brain stimulation technology, is proud to announce the receipt of an Investigational Device Exemption (IDE) from the...

    Movano Health kicks off cuffless blood pressure device study

    Movano Health announced that it commenced a blood pressure clinical trial with its new cuffless wrist wearable. Pleasanton, California-based Movano designed its updated device to...

    Median Technologies’ eyonis™ screening meets primary endpoint in RELIVE clinical trial

    Median Technologies announced that eyonis™ LCS, its wholly owned proprietary AI/ML-based CADe/CADx Software as a Medical Device (SaMD) for lung cancer screening, met the...

    Aethlon Medical treats first subject with Hemopurifier device in Australia

    US-based Aethlon Medical has treated the first subject with its Hemopurifier investigational device in its Australian cancer trial. Designed for subjects with solid tumours, the...

    BrightHeart’s AI demonstrates promise in congenital heart defect detection

    BrightHeart’s AI-based software for prenatal congenital heart defect (CHD) screening has demonstrated promise in two new studies. The French company’s AI software received 510(k) clearance...

    Swiss startup Risklick launches AI-based software for medical device clinical trials

    Risklick, a spin-off from the University of Bern, has launched its latest product, Protocol AI, for medical devices. Protocol AI is the first software of...

    Pulse Biosciences touts positive results from PFA early feasibility study

    Pulse Biosciences has reported positive results from a first-in-human feasibility study evaluating its nanosecond pulsed field ablation (nsPFA) technology for the treatment of atrial...

    Patient enrollment underway for STIMIT’s diaphragm neurostimulation device

    STIMIT AG is enrolling patients in a U.S. Food and Drug Administration Investigational Device Exemption (IDE) clinical trial designed to evaluate its noninvasive diaphragm...
    1234...51Page 3 of 51

    Latest articles

    Popular articles

    Featured

    Newsletter

    [hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

    © Copyright - Guided Solutions - Global Executive Search in Medical Devices